Anthrax is a bacteria-caused disease that affects mammals of the bovine and caprine species, and it causes fatal deaths in humans. The most affected domestic animals include goats, sheep, cattle and horses. It is a fatal disease in animals owing to the fact that, it is transmitted from one herbivorous animal to another the same way as other zoonotic diseases. Anthrax toxins cause fatal effects on the central nervous system, the brain and heart. It is believed that the symptoms and signs presented in anthrax infection are as a result of the toxic effects on some vital organs and systems.
The treatment of anthrax depends on the form of anthrax involved although therapeutic agents target the disease causing pathogen, Bacillus anthracis. As such, antibiotics are used to destroy the anthrax causing bacteria. Some of the most potent antibiotics include penicillin, ciprofloxacin and doxycycline.
Despite the fatality associated with anthrax, reliable preventive and control measures reduce the risk of the disease. From an epidemiological perspective, prevention is usually considered as the most appropriate approach in counteracting the impacts of a given disease. Currently, anthrax is contracted through direct or indirect contact with infected animals in the endemic areas.
Anthrax toxins’ toxicity is extremely fatal because it leads to sudden death if medical intervention is not availed during the initial stages of the disease infection.
Table of Contents
1. Anthrax
Objectives and Topics
This paper aims to provide a comprehensive overview of the anthrax disease, specifically examining its pathophysiology, transmission modes, epidemiological distribution, clinical manifestations, and the strategies for its medical treatment and preventive control.
- Pathophysiology and virulence of Bacillus anthracis
- Primary modes of human infection: cutaneous, gastrointestinal, and inhalation
- Clinical manifestations and impact of lethal and oedema toxins on vital organs
- Therapeutic approaches using antibiotics such as penicillin and ciprofloxacin
- Preventive measures including immunization and public health safety protocols
Excerpt from the Book
Anthrax
Anthrax is a bacteria-caused disease affects mammals of the bovine and caprine species, and it causes fatal deaths in humans. The most affected domestic animals include goats, sheep, cattle and horses. It is a fatal disease in animals owing to the fact that, it is transmitted from one herbivorous animal to another, the same way as other zoonotic diseases. However, it is worth noting that anthrax disease is not common in humans (CDC 2013). Additionally, anthrax is not usually transmitted from one person to another, as it is the case in domestic and wild animals.
Humans acquire anthrax through three principal means: the skin, gastrointestinal tract and the respiratory tract. Infection through the skin is referred to as cutaneous anthrax. This form of anthrax occurs when the anthrax causing bacteria enters the body through open wounds or abrasion, primarily through making contact with the infected animal of carcass. Gastrointestinal infection occurs when an individual ingests infected beef products (CDC 2013). This is usually referred to as gastrointestinal anthrax. Respiratory or inhalation anthrax occurs when an individual inhales the anthrax bacterium spores primarily through breathing air that is contaminated with the anthrax bacteria. This occurs mostly in areas where there is anthrax outbreak. The same case may occur when humans are exposed to anthrax bacteria as a biological weapon.
Summary of Chapters
1. Anthrax: This section introduces the biological nature of the disease, its transmission patterns across species, and the fundamental physiological impacts of Bacillus anthracis infections in humans and animals.
Keywords
Anthrax, Bacillus anthracis, Zoonotic diseases, Cutaneous anthrax, Gastrointestinal anthrax, Inhalation anthrax, Lethal toxin, Oedema toxin, Antibiotics, Ciprofloxacin, Penicillin, Immunization, Pathophysiology, Epidemiology, Biological weapon
Frequently Asked Questions
What is the fundamental subject of this paper?
The paper provides an academic overview of anthrax, covering its causes, transmission, the mechanics of how it affects the human body, and current medical strategies for treatment and prevention.
What are the primary thematic areas covered?
The core themes include the pathophysiology of the bacterium Bacillus anthracis, clinical diagnosis of different infection types, and the epidemiological control measures required to mitigate outbreaks.
What is the primary objective of this research?
The main objective is to delineate the mechanisms through which anthrax toxins lead to fatal health consequences and to summarize effective clinical and preventative protocols.
Which scientific methods are discussed regarding treatment?
The paper discusses the use of broad-spectrum antibiotics, such as penicillin, ciprofloxacin, and doxycycline, and the application of vaccines for high-risk populations.
What is the focus of the main body of the text?
The body explains how the bacterium enters the body, how it produces toxins like the lethal and oedema toxins, and the subsequent systemic failure of the brain, heart, and central nervous system.
Which keywords characterize this work?
Key terms include Bacillus anthracis, lethal toxin, zoonotic transmission, cutaneous/inhalation anthrax, and public health immunization.
How does the lethal toxin specifically affect immune response?
The lethal toxin inhibits the activity of TCR-stimulated MAP Kinase, effectively impairing the host’s immune response to pathogens and tumors.
Why is cutaneous anthrax difficult to diagnose early?
Cutaneous anthrax often presents with painless malignant pustules in the early stages, making it challenging for patients to suspect a microbial infection without professional diagnosis.
What is the significance of the 2001 US incident mentioned?
The 2001 incident serves as a historical case study illustrating how anthrax spores can be weaponized as a biological threat via postal distribution.
- Arbeit zitieren
- Patrick Kimuyu (Autor:in), 2017, Treatment, control and prevention of the Anthrax disease, München, GRIN Verlag, https://www.grin.com/document/381308
